Birth Control News and Research

RSS

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

‘Contraception deserts’ likely to widen under new Trump administration policy

When Nikia Jackson needed to be screened for a sexually transmitted disease, she wanted a clinic that was reputable, quick and inexpensive.

28 Sep 2018

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

According to a new study women of reproductive age who are using the modern oral contraceptive pills or patches and rings that contain a combination of estrogen and progesterone are at a reduced risk for ovarian cancer. The study was published in the recent issue of the British Medical Journal (BMJ).

27 Sep 2018

Beauty products contain mixed chemicals that may harm women's hormones

As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones.

14 Sep 2018

Good skin care practices can help teens to battle stubborn acne

Being a teenager can be tough. Teens must manage high school and the pressures of adolescence while at the same time battling stubborn acne.

6 Sep 2018

Medicaid expansion may fill gap in reproductive health care access, study finds

Medicaid expansion may fill a significant gap in reproductive health care access, especially among young and low-income women, a new Michigan Medicine study finds.

31 Aug 2018

Tips to know your ovarian cancer risk and symptoms

Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.

28 Aug 2018

Biorhythms and birth control: FDA stirs debate by approving ‘natural’ app

The Food and Drug Administration took a "big tent" approach earlier this month when it approved two new forms of birth control that prevent pregnancy in very different ways.

21 Aug 2018

Digital birth control app gets FDA nod

Last week the United States Food and Drug Administration (FDA) announced its approval of the digital birth control app to be sold in the US. The app is called “Natural Cycles” and is one of the first medical devices of this kind to receive the FDA nod.

14 Aug 2018

FDA permits marketing of first mobile medical app for contraceptive use to prevent pregnancy

The U.S. Food and Drug Administration today permitted marketing of the first mobile medical application (app) that can be used as a method of contraception to prevent pregnancy.

13 Aug 2018

FDA approves first vaginal ring contraceptive that can be used for one year

The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

10 Aug 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

Breastfeeding makes babies smarter and saves money

A debate over breastfeeding fueled by a New York Times article on Monday centered on whether the U.S. threatened trade measures against Ecuador, which had proposed a resolution to the World Health Assembly that would prioritize breastfeeding over formula.

11 Jul 2018

Combe announces launch of Preventeza Emergency Contraceptive and campaign

Combe Inc., the makers of Vagisil, today announced the launch of its Preventeza Emergency Contraceptive #WeAre1in2 campaign to showcase solidarity around women's reproductive rights.

6 Jul 2018

Study shows prevalence of medications with potential to cause depression among U.S. adults

A new study from University of Illinois at Chicago researchers suggests that more than one-third of U.S. adults may be using prescription medications that have the potential to cause depression or increase the risk of suicide, and that because these medications are common and often have nothing to do with depression, patients and health care providers may be unaware of the risk.

12 Jun 2018

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

A Trump administration effort to shift family planning funding toward groups that may not provide comprehensive services and away from organizations that provide abortions could cripple other federal efforts to curb an explosion in sexually transmitted diseases, some public health officials fear.

12 Jun 2018

‘Where the need is’: Tackling teen pregnancy with a midwife at school

The student comes in for a pregnancy test — the second time she has asked for one in a matter of weeks. She’s 15. She lives with her boyfriend. He wants kids — he won’t use protection. She loves him, she says. But she doesn’t want to get pregnant. She knows how much harder it would be for her to finish high school.

12 Jun 2018

Researchers investigate if stabilization of ovarian hormones can reduce suicide risk

A three-year, $750,000 grant from the National Institutes of Mental Health will help researchers determine whether the stabilization of ovarian hormones estradiol and progesterone can help lower symptoms associated with suicidality among females at risk for suicide.

5 Jun 2018

Study: Symptoms of borderline personality disorder tend to worsen around menses

Symptoms associated with borderline personality disorder -; a severe and chronic mood disorder characterized by an inability to manage strong emotions -; tend to worsen just before and during menses, according to a study in Psychological Medicine.

1 Jun 2018